REGENXBIO Inc
Price
FilingsNewest: Form 13G, stake over 5%, passiveNov 10 →Insiders1 insider bought $949,541 in 2 open-market buys. 1 insider sold $939,970, 3 of 5 sales on a 10b5-1 plan.→HoldersBlackRock 9.7%Redmile 6.6%State Street 4.5%→Financing →PeersClosest companies: DNLI, LXEO, PASG→
From the filings
Figures
- Revenue
- $153.9Mlast 12 months
- Net income
- −$175.2Mlast 12 months
- Operating cash flow
- −$246.7Mlast 12 months
- Cash and equivalents
- $95.8Mat the last balance sheet
- Shares outstanding
- 66.1M shareson issue
Filings, newest first
- Nov 1013GStake over 5%, passive
- Nov 510-QQuarterly report
- Nov 58-KResults of operations
- Nov 34Insider trade
- Nov 34Insider trade
- Oct 168-KDirector or officer change
- Oct 1313GStake over 5%, passive
- Sep 238-KMaterial agreement
- Aug 258-KDirector or officer change
- Aug 248-KRegulation FD disclosure
- Mar 510-KAnnual report